1
|
Sari C, Demirbağ BC. Investigation of anxiety levels in caregivers who perform clean intermittent catheterization on their children and affecting factors. Neurourol Urodyn 2024; 43:738-747. [PMID: 38238988 DOI: 10.1002/nau.25388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Revised: 11/20/2023] [Accepted: 12/21/2023] [Indexed: 03/21/2024]
Abstract
PURPOSE The study aimed to determine the anxiety levels of caregivers who performed clean intermittent catheterization (CIC) on their children and the factors affecting them. METHODS This descriptive study was conducted between January 6, and May 29, 2023 with caregivers of 42 patients who were followed up by the pediatric nephrology outpatient clinic of a university for CIC. The study data were collected using the "Participant Information Form" and the "State and Trait Anxiety Scale." RESULTS According to the results, of the children included in the study, 73.8% were female, 64.3% were diagnosed with spina bifida (SB), and 76.2% received CIC applications 4-6 times a day. All the caregivers were mothers, and 76.2% received CIC training from a doctor. However, 78.6% of them found the training insufficient, leading them to rely on self-experimentation when applying CIC to their own children. None of the caregivers received information or training on the CIC application from nurses, and there were no home visits or telephone counseling provided after the hospital discharge. The mean score for the state anxiety scale among the caregivers was 45.90 ± 10.57, while the mean score for the trait anxiety scale was 46.92 ± 8.43. Significantly higher mean trait anxiety scores were observed among caregivers with chronic diseases who did not receive training on the CIC application (p < 0.05). Additionally, caregivers of children who experienced 3-4 urinary tract infections (UTIs) within the last 3 months also had significantly higher mean trait anxiety scores (p < 0.05). The mean trait anxiety level scores of caregivers of children who had 3-4 UTIs in the last 3 months were significantly higher (p < 0.05). CONCLUSIONS It was concluded that caregivers' lack of training on CIC implementation, having chronic disease, and having frequent UTIs in their children were effective on anxiety levels.
Collapse
Affiliation(s)
- Canan Sari
- Department of Health Care Services, Elderly Care Program, Tonya Vocational School, Trabzon University, Trabzon, Turkey
| | - Birsel C Demirbağ
- Faculty of Health Sciences, Public Health Nursing AB, Karadeniz Technical University, Trabzon, Turkey
| |
Collapse
|
2
|
Santos-Pérez de la Blanca R, Medina-Polo J, González-Padilla D, Cano-Galán MM, Arrébola-Pajares A, Hernández-Arroyo M, Rodríguez-Antolín A. Evaluation of Quality of Life and Self-reported Complications in Patients With Clean Intermittent Catheterization: An Observational Study. J Wound Ostomy Continence Nurs 2023; 50:400-405. [PMID: 37713351 DOI: 10.1097/won.0000000000001002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/17/2023]
Abstract
PURPOSE This study sought to determine health-related quality of life and self-reported complications associated with clean intermittent catheterization (CIC). DESIGN Observational, cross-sectional study. SUBJECTS AND SETTING The target population was patients cared for by the urology department at Hospital 12 de Octubre in Madrid, Spain, undergoing CIC for chronic urinary retention of any etiology (neurogenic bladder dysfunction, neobladder, and other). The sample comprised 50 respondents with a mean age of 49 years; a majority (66%, n = 33) were female. Participants performed an average of 4 CICs. METHODS All participants completed the ISC-Q (Intermittent Self-Catheterization Questionnaire) and a questionnaire about CIC-associated complications. Data were collected in February 2019. RESULTS A vast majority of respondents (98%, n = 49) indicated preparation for catheterization was simple, and 76% (n = 38) indicated the catheter was easy to insert. One in 5 (20%, n = 10) considered carrying catheters and supplies inconvenient, though 58% (n = 29) indicated it was easy to dispose of the catheters outside the home. Most respondents (98%, n = 49) indicated they felt self-conscious about their need to self-catheterize, and 16% (n = 8) felt that CIC created limitations when visiting friends and family. The most frequent complication was symptomatic urinary tract infections (UTIs); participants reported an average of 1.7 UTIs in the last year. Additional complications, such as epididymo-orchitis, urethral stenosis, and urethral bleeding, were reported by less than 5% (n = 2) of participants. CONCLUSIONS Participants managed by CIC for chronic urinary retention of any cause reported acceptable levels of satisfaction with the procedure. The reported incidence of complications was low, except for UTIs.
Collapse
Affiliation(s)
- Rocío Santos-Pérez de la Blanca
- Rocío Santos-Pérez de la Blanca, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- José Medina-Polo, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Daniel González-Padilla, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- María Mercedes Cano-Galán, Nurse, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Ana Arrébola-Pajares, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Mario Hernández-Arroyo, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Alfredo Rodríguez-Antolín, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
| | - José Medina-Polo
- Rocío Santos-Pérez de la Blanca, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- José Medina-Polo, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Daniel González-Padilla, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- María Mercedes Cano-Galán, Nurse, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Ana Arrébola-Pajares, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Mario Hernández-Arroyo, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Alfredo Rodríguez-Antolín, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
| | - Daniel González-Padilla
- Rocío Santos-Pérez de la Blanca, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- José Medina-Polo, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Daniel González-Padilla, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- María Mercedes Cano-Galán, Nurse, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Ana Arrébola-Pajares, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Mario Hernández-Arroyo, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Alfredo Rodríguez-Antolín, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
| | - María Mercedes Cano-Galán
- Rocío Santos-Pérez de la Blanca, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- José Medina-Polo, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Daniel González-Padilla, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- María Mercedes Cano-Galán, Nurse, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Ana Arrébola-Pajares, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Mario Hernández-Arroyo, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Alfredo Rodríguez-Antolín, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
| | - Ana Arrébola-Pajares
- Rocío Santos-Pérez de la Blanca, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- José Medina-Polo, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Daniel González-Padilla, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- María Mercedes Cano-Galán, Nurse, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Ana Arrébola-Pajares, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Mario Hernández-Arroyo, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Alfredo Rodríguez-Antolín, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
| | - Mario Hernández-Arroyo
- Rocío Santos-Pérez de la Blanca, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- José Medina-Polo, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Daniel González-Padilla, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- María Mercedes Cano-Galán, Nurse, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Ana Arrébola-Pajares, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Mario Hernández-Arroyo, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Alfredo Rodríguez-Antolín, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
| | - Alfredo Rodríguez-Antolín
- Rocío Santos-Pérez de la Blanca, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- José Medina-Polo, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Daniel González-Padilla, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- María Mercedes Cano-Galán, Nurse, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Ana Arrébola-Pajares, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Mario Hernández-Arroyo, MD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
- Alfredo Rodríguez-Antolín, PhD, Department of Urology, University Hospital 12 de Octubre Imas12, Madrid, Spain
| |
Collapse
|
3
|
Liu J, Bi Y, Liu Y, Tang L, Wang A. Value of sufficient clean intermittent catheterization in urinary tract infection and upper urinary tract protection in children with neurogenic bladder. J Pediatr Urol 2022; 18:499.e1-499.e6. [PMID: 35527206 DOI: 10.1016/j.jpurol.2022.04.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/30/2021] [Revised: 04/08/2022] [Accepted: 04/14/2022] [Indexed: 11/24/2022]
Abstract
INTRODUCTION Clean intermittent catheterization (CIC) is a mainstay in the management of neurogenic bladder. OBJECTIVE To assess the effect of CIC on urinary tract infection and upper renal tract function in pediatric patients with neurogenic bladder, and the influence of duration of CIC on these variables. STUDY DESIGN A retrospective study was performed in 67 pediatric patients with neurogenic bladder who started CIC between 2014 and 2019 at our institution. The febrile urinary tract infection (fUTI) rate, renal pelvis diameter (measured by antero-posterior renal pelvis diameter, APPD), bladder wall thickness (BWT) on ultrasound, and creatinine level at 6 months and 12 months of CIC were compared with baseline in all patients. The grade of vesicoureteral reflux (VUR) at 12 months of CIC were also compared with baseline. RESULTS There were no significant differences compared with baseline after 6 months of CIC in the rate of fUTI, APPD, and BWT (p > 0.05); however, all of these parameters significantly improved after 12 months of CIC (p < 0.05). The VUR grade was significantly reduced after 12 months of CIC(p = 0.03). There was no significant change in serum creatinine level with any duration of CIC (both p > 0.05). DISCUSSION Continuing CIC for more than 6 months had a beneficial influence on protecting the upper urinary tract. Complications of CIC, such as recurrent fUTI and lower urinary tract trauma, are more likely to occur in the early stage of CIC due to poor technique by the caregivers and poor patient compliance underscoring the importance of caregiver education. Study limitations include the retrospective nature and small sample size. CONCLUSION CIC for less than 6 months may have limited influence on renal protection; however, a longer duration of CIC (12 months) resulted in significant improvement in outcomes. This study demonstrates the importance of proper caregiver education to establish standardized CIC techniques and to improve CIC quality.
Collapse
Affiliation(s)
- Jialin Liu
- Department of Urology, Children's Hospital of Fudan University, 399 Wanyuan Road, Minhang District, Shanghai, 201102, China.
| | - Yunli Bi
- Department of Urology, Children's Hospital of Soochow University, 92# Zhongnan Street, SIP, Suzhou, 215025, China.
| | - Ying Liu
- Department of Urology, Children's Hospital of Fudan University, 399 Wanyuan Road, Minhang District, Shanghai, 201102, China.
| | - Liangfeng Tang
- Department of Urology, Children's Hospital of Fudan University, 399 Wanyuan Road, Minhang District, Shanghai, 201102, China.
| | - Anle Wang
- Department of Urology, Children's Hospital of Fudan University, 399 Wanyuan Road, Minhang District, Shanghai, 201102, China.
| |
Collapse
|
4
|
Gharbi M, Gazdovich S, Bazinet A, Cornu JN. Quality of life in neurogenic patients based on different bladder management methods: A review. Prog Urol 2022; 32:784-808. [DOI: 10.1016/j.purol.2022.07.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2022] [Revised: 06/26/2022] [Accepted: 07/01/2022] [Indexed: 02/06/2023]
|
5
|
Roberson D, Newman DK, Ziemba JB, Wein A, Stambakio H, Hamilton RG, Callender L, Holderbaum L, King T, Jackson A, Tran T, Lin G, Smith AL. Results of the patient report of intermittent catheterization experience (PRICE) study. Neurourol Urodyn 2021; 40:2008-2019. [PMID: 34516673 DOI: 10.1002/nau.24786] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2020] [Revised: 08/13/2021] [Accepted: 08/19/2021] [Indexed: 02/02/2023]
Abstract
AIMS Patient satisfaction is paramount to health-related quality of life (HR-QoL) outcomes. High quality, quantitative data from the US describing patients' actual experiences, difficulties, and HR-QoL while on an intermittent self-catheterization (ISC) regimen is very scarce. Our objective was to better understand patient practices with and attitudes towards ISC. METHODS This is a cross-sectional, multi-centered, clinical study of adult men and women performing ISC in the United States. Data collected included demographics, medical history, catheter characteristics, specific self-catheterization habits and two validated HR-QoL questionnaires: The Intermittent Self-Catheterization Questionnaire (ISC-Q) and the Intermittent Catheterization Difficulty Questionnaire (ICDQ). RESULTS Two hundred participants were recruited from six sites; 70.0% were male, 73.5% were Caucasian with a median age was 51.0 years (range 19-90 years). The ISC-Q showed that the vast majority of participants reported ease with ISC (82.0% satisfaction score) had confidence in their ability to perform ISC (91.9% satisfaction score); yet, many felt self-conscious about doing so (58.3% satisfaction score) and had concerns about long-term adverse effects (58.1% satisfaction score). The ICDQ indicated little to no difficulty for most participants with all routine ISC practices. A small minority of participants reported some difficulty with a "blocking sensation" during initiation of catheterization, leg spasticity, and painful catheterization. Multivariate linear regression results are also reported. DISCUSSION/CONCLUSION Participants are confident with ISC and have little overall difficulty, which may be a product of successful education and/or catheter design. urinary tract infections (UTIs) were common (yet variable) and may contribute to the noted long-term ISC concerns. Limitations exist including various selection biases leading to concerns of external validity. Future educational interventions in this population may further improve HR-QoL, optimize UTIs prevention, and diminish concerns with long-term ISC.
Collapse
Affiliation(s)
- Daniel Roberson
- Division of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Diane K Newman
- Division of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Justin B Ziemba
- Division of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Alan Wein
- Division of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Hanna Stambakio
- Division of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Rita G Hamilton
- Baylor Scott & White Institute for Rehabilitation, Dallas, Texas, USA
| | - Librada Callender
- Baylor Scott & White Institute for Rehabilitation, Dallas, Texas, USA
| | - Leah Holderbaum
- Baylor Scott & White Institute for Rehabilitation, Dallas, Texas, USA
| | - Tamara King
- Shepherd Multispecialty Clinic, Shepherd Center, Inc., Atlanta, Georgia, USA
| | - Angela Jackson
- Department of Urology, University of South Florida, Tampa, Florida, USA
| | - Thanh Tran
- Department of Urology, University of South Florida, Tampa, Florida, USA
| | - George Lin
- Division of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Ariana L Smith
- Division of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| |
Collapse
|
6
|
Zhu GQ, Jeon SH, Lee KW, Cho HJ, Ha US, Hong SH, Lee JY, Kwon EB, Kim HJ, Lee SM, Kim HY, Kim SW, Bae WJ. Engineered Stem Cells Improve Neurogenic Bladder by Overexpressing SDF-1 in a Pelvic Nerve Injury Rat Model. Cell Transplant 2021; 29:963689720902466. [PMID: 32067480 PMCID: PMC7444235 DOI: 10.1177/0963689720902466] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
There is still a lack of sufficient research on the mechanism behind neurogenic
bladder (NB) treatment. The aim of this study was to explore the effect of
overexpressed stromal cell-derived factor-1 (SDF-1) secreted by engineered
immortalized mesenchymal stem cells (imMSCs) on the NB. In this study, primary
bone marrow mesenchymal stem cells (BM-MSCs) were transfected into immortalized
upregulated SDF-1-engineered BM-MSCs (imMSCs/eSDF-1+) or immortalized normal SDF-1-engineered BM-MSCs
(imMSCs/eSDF-1−). NB rats induced by bilateral pelvic nerve (PN)
transection were treated with imMSCs/eSDF-1+, imMSCs/eSDF-1−, or sham. After a 4-week treatment, the bladder function was assessed by
cystometry and voiding pattern analysis. The PN and bladder tissues were
evaluated via immunostaining and western blotting analysis. We found that imMSCs/eSDF-1+ expressed higher levels of SDF-1 in vitro and in vivo. The treatment of imMSCs/eSDF-1+ improved NB and evidently stimulated the recovery of bladder wall in NB
rats. The recovery of injured nerve was more effective in the NB+imMSCs/eSDF-1+ group than in other groups. High SDF-1 expression improved the levels of
vascular endothelial growth factor and basic fibroblast growth factor. Apoptosis
was decreased after imMSCs injection, and was detected rarely in the NB+imMSCs/eSDF-1+ group. Injection of imMSCs boosted the expression of neuronal nitric
oxide synthase, p-AKT, and p-ERK in the NB+imMSCs/eSDF-1+ group than in other groups. Our findings demonstrated that overexpression
of SDF-1 induced additional MSC homing to the injured tissue, which improved the
NB by accelerating the restoration of injured nerve in a rat model.
Collapse
Affiliation(s)
- Guan Qun Zhu
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.,Catholic Integrative Medicine Research Institute, The Catholic University of Korea, Seoul, Republic of Korea
| | - Seung Hwan Jeon
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.,Catholic Integrative Medicine Research Institute, The Catholic University of Korea, Seoul, Republic of Korea
| | - Kyu Won Lee
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Hyuk Jin Cho
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - U-Syn Ha
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Sung-Hoo Hong
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Ji Youl Lee
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Eun Bi Kwon
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.,Catholic Integrative Medicine Research Institute, The Catholic University of Korea, Seoul, Republic of Korea
| | - Hyo-Jin Kim
- Department of Stem Cell Therapy, SL BIGEN, Seongnam, Republic of Korea
| | - Soon Min Lee
- Department of Stem Cell Therapy, SL BIGEN, Seongnam, Republic of Korea
| | - Hey-Yon Kim
- Department of Stem Cell Therapy, SL BIGEN, Seongnam, Republic of Korea
| | - Sea Woong Kim
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.,Catholic Integrative Medicine Research Institute, The Catholic University of Korea, Seoul, Republic of Korea
| | - Woong Jin Bae
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.,Catholic Integrative Medicine Research Institute, The Catholic University of Korea, Seoul, Republic of Korea
| |
Collapse
|
7
|
Komatsu H, Oishi T, Osaku D, Kudoh A, Shimogai R, Chikumi J, Sato S, Harada T. Long-term evaluation of renal function and neurogenic bladder following radical hysterectomy in patients with uterine cervical cancer. J Obstet Gynaecol Res 2020; 46:2108-2114. [PMID: 32686280 DOI: 10.1111/jog.14394] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2020] [Revised: 06/12/2020] [Accepted: 06/20/2020] [Indexed: 11/28/2022]
Abstract
OBJECTIVE This study aimed to determine whether radical hysterectomy (RH) affects renal function. METHODS Renal function was followed up in 83 patients with stage IB1-IIB cervical cancer who underwent RH during 2006-2015. Serum creatinine (sCre) levels were measured preoperatively and every year postoperatively. Estimated glomerular filtration rate (eGFR) was calculated using sCre levels. Patients who were unable to urinate by themselves or whose residual urine was ≥100 mL were referred to a urologist with the diagnosis of neurogenic bladder (NB). The relationship between NB occurrence and changes in sCre level or eGFR was evaluated respectively. RESULTS Urological intervention was required in 45 patients (54.2%), and self-urethral catheterization was performed in 41 (49.3%) patients. The NB and clean intermittent catheterization (CIC) groups exhibited significant increases in sCre levels, which were not observed in the non-NB or non-CIC groups. In the non-NB group, eGFR did not change following surgery. However, in the NB group, significant decreases in eGFRs were observed at postoperative 2 and 3 years and at final follow-up. There was no difference in the incidence of cardiovascular events between patients with and without NB. CONCLUSION In patients with NB following RH, a significant decrease in renal function was observed after postoperative 2 years.
Collapse
Affiliation(s)
- Hiroaki Komatsu
- Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Tottori, Japan
| | - Tetsuro Oishi
- Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Tottori, Japan
| | - Daiken Osaku
- Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Tottori, Japan
| | - Akiko Kudoh
- Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Tottori, Japan
| | - Ruri Shimogai
- Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Tottori, Japan
| | - Jun Chikumi
- Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Tottori, Japan
| | - Shinya Sato
- Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Tottori, Japan
| | - Tasuku Harada
- Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Tottori, Japan
| |
Collapse
|
8
|
Vikartovska Z, Kuricova M, Farbakova J, Liptak T, Mudronova D, Humenik F, Madari A, Maloveska M, Sykova E, Cizkova D. Stem Cell Conditioned Medium Treatment for Canine Spinal Cord Injury: Pilot Feasibility Study. Int J Mol Sci 2020; 21:ijms21145129. [PMID: 32698543 PMCID: PMC7404210 DOI: 10.3390/ijms21145129] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2020] [Revised: 07/14/2020] [Accepted: 07/14/2020] [Indexed: 12/15/2022] Open
Abstract
Spinal cord injury (SCI) involves nerve damage and often leads to motor, sensory and autonomic dysfunctions. In the present study, we have designed a clinical protocol to assess the feasibility of systemic delivery of allogenic canine bone marrow tissue-derived mesenchymal stem cell conditioned medium (BMMSC CM) to dogs with SCI. Four client-owned dogs with chronic SCI lasting more than six months underwent neurological and clinical evaluation, MRI imaging and blood tests before being enrolled in this study. All dogs received four intravenous infusions with canine allogenic BMMSC CM within one month. Between the infusions the dogs received comprehensive physiotherapy, which continued for three additional months. No adverse effects or complications were observed during the one, three and six months follow-up periods. Neither blood chemistry panel nor hematology profile showed any significant changes. All dogs were clinically improved as assessed using Olby locomotor scales after one, three and six months of BMMSC CM treatment. Furthermore, goniometric measurements revealed partial improvement in the range of joint motion. Bladder function improved in two disabled dogs. We conclude that multiple delivery of allogenic cell-derived conditioned medium to dogs with chronic SCI is feasible, and it might be clinically beneficial in combination with physiotherapy.
Collapse
Affiliation(s)
- Zuzana Vikartovska
- Center of Experimental and Clinical Regenerative Medicine, University of Veterinary Medicine and Pharmacy, Komenskeho 73, 04181 Kosice, Slovakia; (Z.V.); (F.H.); (M.M.)
- University Veterinary Hospital, University of Veterinary Medicine and Pharmacy, Komenskeho 73, 04181 Kosice, Slovakia; (M.K.); (J.F.); (T.L.); (A.M.)
| | - Maria Kuricova
- University Veterinary Hospital, University of Veterinary Medicine and Pharmacy, Komenskeho 73, 04181 Kosice, Slovakia; (M.K.); (J.F.); (T.L.); (A.M.)
| | - Jana Farbakova
- University Veterinary Hospital, University of Veterinary Medicine and Pharmacy, Komenskeho 73, 04181 Kosice, Slovakia; (M.K.); (J.F.); (T.L.); (A.M.)
| | - Tomas Liptak
- University Veterinary Hospital, University of Veterinary Medicine and Pharmacy, Komenskeho 73, 04181 Kosice, Slovakia; (M.K.); (J.F.); (T.L.); (A.M.)
| | - Dagmar Mudronova
- Department of Microbiology and Immunology, Institute of Immunology, University of Veterinary Medicine and Pharmacy, Komenskeho 73, 04181 Kosice, Slovakia;
| | - Filip Humenik
- Center of Experimental and Clinical Regenerative Medicine, University of Veterinary Medicine and Pharmacy, Komenskeho 73, 04181 Kosice, Slovakia; (Z.V.); (F.H.); (M.M.)
| | - Aladar Madari
- University Veterinary Hospital, University of Veterinary Medicine and Pharmacy, Komenskeho 73, 04181 Kosice, Slovakia; (M.K.); (J.F.); (T.L.); (A.M.)
| | - Marcela Maloveska
- Center of Experimental and Clinical Regenerative Medicine, University of Veterinary Medicine and Pharmacy, Komenskeho 73, 04181 Kosice, Slovakia; (Z.V.); (F.H.); (M.M.)
| | - Eva Sykova
- Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9, 845 10 Bratislava, Slovakia;
| | - Dasa Cizkova
- Center of Experimental and Clinical Regenerative Medicine, University of Veterinary Medicine and Pharmacy, Komenskeho 73, 04181 Kosice, Slovakia; (Z.V.); (F.H.); (M.M.)
- Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9, 845 10 Bratislava, Slovakia;
- Correspondence:
| |
Collapse
|
9
|
Cho EK, Jeon SH. Histological Examination of Engineered Mesenchymal Stem Cells Improve Bladder Function in Rat. KOREAN JOURNAL OF CLINICAL LABORATORY SCIENCE 2020. [DOI: 10.15324/kjcls.2020.52.2.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Affiliation(s)
- Eun Kyung Cho
- Department of Biomedical Laboratory Science, Kyungwoon University, Gumi, Korea
| | - Seung Hwan Jeon
- Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Korea
| |
Collapse
|
10
|
Grzybowska ME, Wydra D. 24/7 usage of continence pads and quality of life impairment in women with urinary incontinence. Int J Clin Pract 2019; 73:e13267. [PMID: 30230139 DOI: 10.1111/ijcp.13267] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/23/2018] [Accepted: 09/04/2018] [Indexed: 12/01/2022] Open
Abstract
AIMS To compare quality of life (QoL) in women with urinary incontinence (UI) using continence pads during the day versus all day and night; to identify risk factors for a 24-hour pad use; to calculate quality-adjusted life years (QALY). METHODS A cross-sectional study in 331 women with lower urinary tract symptoms referred to urogynaecologic examination was conducted. Main outcome measures were the scores of King's Health Questionnaire (KHQ), clinical data, and KHQ-derived utility values. RESULTS A total of 270 women with UI were recruited: 176 (57.3%) using continence pads only during the day (group I) and 94 (30.6%) for 24 hours (group II). The groups did not differ in terms of age, menopause, parity, type of UI, stage of POP-Q, and percentage of sexually active subjects. Group II had significantly higher body mass index (BMI) and lower education than group I (P < 0.05). QoL was significantly deteriorated in group II in KHQ Global score and in all domains except one (General Health). Risk factors for 24 hours pad use were as follows: BMI ≥ 30 vs BMI 25-30 (OR = 2.02 (1.09-3.73), P = 0.037), higher scores in KHQ Severity measures (OR = 1.03 (1.02-1.04), P < 0.001), KHQ Global score (OR = 1.03 (1.02-1.05), P < 0.001) and primary compared to secondary (OR = 0.4 (0.19-0.84)) or higher education (OR = 0.41 (0.18-0.94), P < 0.05). Annual QALY was significantly lower in group II (0.9288 ± 0.03 vs 0.9432 ± 0.03, P < 0.001). CONCLUSION One-third of women with UI used continence pads for 24 hours. Among these patients QoL and QALY were found lower compared to women using continence pads only during the day. KHQ Severity measures domain was an independent predictor for a 24-hour usage of continence pads.
Collapse
Affiliation(s)
- Magdalena Emilia Grzybowska
- Department of Gynecology, Gynecologic Oncology and Gynecologic Endocrinology, Medical University of Gdańsk, Gdańsk, Poland
| | - Dariusz Wydra
- Department of Gynecology, Gynecologic Oncology and Gynecologic Endocrinology, Medical University of Gdańsk, Gdańsk, Poland
| |
Collapse
|